Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Peptide-acceptor-ligation-methods

 Antisense modulation of interleukin-5 signal transduction
OF THE INVENTION The present invention comprehends antisense compounds capable of modulating IL-5 ...


 Antisense modulation of P38 mitogen activated protein kinase expression
OF THE INVENTION p38 MAPKs play an important role in signal transduction in response to cytokines, ...


 Antisense modulation of CD44 expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ...


 Antisense modulation of Smad7 expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ...


 Antisense modulation of nucleolin expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ...


 Antisense modulation of hnRNP A1 expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ...


 Antisense inhibition of E2F transcription factor 3 expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ...


 Antisense inhibition of rank expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ...


 Antisense inhibition of protein kinase C-theta expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ...


 Antisense oligonucleotide modulation of human mdm2 expression
OF THE INVENTION Tumors often result from genetic changes in cellular regulatory genes. Among the ...


 Peptide acceptor ligation methods

Details
Inventors: Kurz, Markus; Lohse, Peter; Wagner, Richard;
Assignee: Compound Therapeutics, Inc. (Waltham, MA)
Primary Examiner: Ketter; James
Assistant Examiner:
Attorney, Agent or Firm: Fish & Neave IP Group of Ropes & Gray LLP

Described herein are methods and reagents for the ligation of a peptide acceptor to an RNA, as well as the RNA-peptide acceptor products.

DETAILED DESCRIPTION What is claimed is: 1.
A method of affixing a peptide acceptor to an RNA molecule, said method comprising: (a) providing an RNA molecule having a 3' sequence which forms a hairpin structure; (b) providing a peptide acceptor covalently bonded to a nucleic acid linker molecule; and (c) hybridizing said RNA molecule to said nucleic acid linker molecule under conditions which allow covalent bond formation to occur between said peptide acceptor and said RNA molecule.
2.
The method of claim 1, wherein said covalent bond formation is catalyzed by T4 DNA ligase.
3.
A method of affixing a peptide acceptor to an RNA molecule, comprising: (a) providing an RNA molecule; (b) providing a peptide acceptor covalently bonded to a linker molecule, wherein the 5' sequence of said linker molecule forms a nucleic acid hairpin structure; and (c) hybridizing said RNA molecule to said linker molecule under conditions which allow covalent bond formation to occur between said peptide acceptor and said RNA molecule.
4.
The method of claim 3, wherein said covalent bond formation is catalyzed by T4 DNA ligase.
5.
The method of claim 3, wherein said RNA molecule comprises a translation initiation sequence and a start codon operably linked to a protein coding sequence.
6.
The method of claim 3, wherein said peptide acceptor is puromycin.
7.
The method of claim 3, wherein said linker molecule further comprises non-nucleotide moieties.
8.
The method of claim 7, wherein said non-nucleotide moieties comprises triethylene glycol spacers.
9.
The method of claim 7, wherein said non-nucleotide moieties comprises 2'-OMe-RNA phosphoramidites.
10.
The method of claim 3, wherein said RNA or said linker contains an affinity purification sequence and said method further comprises purifying said RNA.
11.
The method of claim 10, wherein said affinity purification sequence comprises a poly (A) sequence.




Description:



Related patents
  Solid phase diagnosis of medical conditions
I claim: 1. A method for detecting a target polynucleotide that is characteristic of a pathological condition, comprising the steps of: (a) producing a first amplified DN...
  Use of microparticles combined with submicron oil-in-water emulsions
OF THE INVENTION The practice of the present invention will employ, unless otherwise indicated, conventional methods of chemistry, biochemistry, molecular biology, ...
  Methods of treating hypertension and compositions for use therein
The present invention provides methods of treating hypertension, particularly essential hypertension. The methods generally involve providing a stimulator of ...
  Use of microparticles combined with submicron oil-in-water emulsions
OF THE INVENTION The practice of the present invention will employ, unless otherwise indicated, conventional methods of chemistry, biochemistry, molecular biology, ...
  6,11-bicyclic erythromycin derivatives
OF THE INVENTION A first embodiment of the present invention is a compound of formula I as defined herein, or its pharmaceutically acceptable salt, ester, or prodrug. R...
  Method of producing infectious reovirus
OF THE INVENTION The present invention is directed to a method of producing mammalian reovirus by using human embryo kidney 293 (HEK 293) cells. We found that HEK 293 ...
  CDNA sequences of human bone matrix proteins
It is, therefore, an object of the present invention to provide specific cDNA and deduced protein sequences which are diagnostic of such human diseases as osteoporosis, ...
  Antisense inhibition of PEPCK-mitochondrial expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly oligonucleotides, for use in modulating the function of nucleic acid ...
  Methods of modulating tumor necrosis factor .alpha.-induced expression of cell adhesion molecules
OF THE INVENTION The present invention employs specific inhibitors of Ha-ras, c-raf and JNK2, members of the TNF-.alpha. signaling pathway, to modulate cell adhesion ...
  Antisense modulation of telomeric repeat binding factor 1 expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly oligonucleotides, for use in modulating the function of nucleic acid ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved